Member Info for MrRipley

Do you want me to dig up the RNS for Conifer going below 3% or do you want to just accept you’re wrong?

It’s 3%. That’s just a fact.

I don’t think that’s accurate if it’s from February. This is from July.

https://avacta.com/investors/key-information/

06-Sep-22 09:02:15 112.375 100,000 Buy* 112.38k

We have a buyer.

We’re going nowhere while mr 50k keeps dumping in perfectly timed blocks.

Last time I worked that hard was after 3 days in Catterick on a diet of Biscuit Browns. I’ll never get those haemorrhoids back in but this shafting from the MMs is having a good go.

The basher. Binned. Part of the TW crew

It’s the day after an RNS. And as we all know, it’s the second most powerful instigator of a bull run after an RNS at ODX to say they’re out of milk in the coffee machine. Cortado please Merchant, when you’re ready pal.

How Avacta have taken Doxorubicin from a toxic Red Devil that barely makes its way into a tumour, into one that is found Predominantly within the tumour. What an absolute show stopping piece of news this is and I thank Reisgo for highlighting this use of language as a means of proving that not only is it entering the tumour but it must also be being activated. Why I hear you ask Reisgo? Well because if it’s only activated by FAP and FAP is found predominantly in the tumour and only in small volumes outside of it, then it must be being activated mustn’t it? That’s the spin I’m going for.

And as for rude, put your cork back in you pointless twat.

I suggest others email them too.

Hanoi. It’s literally their job to keep up investor relations. Avacta can put it to bed with a simple RNS.

I’ve emailed them asking if there will be an RNS in response to media speculation about TWs article. ODX responded to him doing one about them so Avacta have no reason not to do the same.

I didn’t actually. It spell checked to Wyndrone hahaha. I have now though. It’s boring. He’s in my inside pocket for life. I realised now without me he doesn’t exist. I am his lord and saviour on this board. That’s why he jumps on my every post like a happing pup. Anyway he’s in the pound now.

“If somebody here actually wants to try to discuss why the SP has been relatively low for so long after a pretty good stream of positive RNS's you just get on your personally abusive high horse and then get the thread deleted under "disruption"”

I’ve discussed it to death including an entire thread this morning and I’ve never once had a thread removed. You’re holding a mirror to yourself and I won’t be drawn into an argument. Have a lovely day.

Wyn. I try to counter it. That’s all. It’s on Twitter. Twitter is quite popular. It’s also popped up on LSE. You profess to want the other side discussed….. I’m not getting into it with you again. Stop responding to my posts and I’ll stop highlighting what a clown you are. Binned.

They’re ****ting themselves. Especially Wres. If they close it’ll shove us north by a good chunk and spook the market into a bull run and they compound their losses. They desperately need a panic and they’re failing. They’ve got circa 5-7 weeks to get it done or they’re absolutely ****ed.

https://mobile.twitter.com/bullish7777

Thanks Wres.

Written in a rush on my lunch. So apologies if it makes no sense. Basically Tom Tombstone teeth is getting his mates to bash us. The issue they have is they’re too stupid to use an alias. Rather they’re too egotistical to not have a little photo of their ugly kites next to the articles they hammer out with their massive, swollen, gout riddled fingers.

And pop this on Twitter for me.

https://mobile.twitter.com/Asktraders1/status/1566739818897440769

Absolutely **** poor I’ll informed article on Avacta. So poor in fact that it’s suspicious. So I did some sleuthing. The article is by a twat named Tim Worstall.

https://www.tomwinnifrith.com/

Go to the bottom of the page. Look at number 7 on his also read recommendations. It’s our new pal…. Tim Worstall.

So Tom Winnit breath now has other authors doing their bit to attack Avacta. I’m certain there’s a series of shorts on us under 0.5% that they’re struggling to maintain. My advice is burn the bastards. Buy. Hold. (Obviously DYOR etc)

Agreed Timster and Mr A. Funding isn’t the massive negative it’s painted to be but it does give MMs a chance to create havoc. As pointed out if data is great and the trials continue to be a success, dilution, though not ideal when there’s other option for funding, would simply fund a potential multi multi billion £ drug to market.